CLASS II Device recall · Reported 9 Oct 2013 · FDA Enforcement Report

Flixene Trumpet Grafts >or= Flixene GW recalled by Atrium Medical

Atrium Medical is recalling Flixene Trumpet Grafts >or= Flixene GW and GWT Grafts >or= Intended for use in arterial, distributed nationwide in the US. The recall was initiated on 12 Jul 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesProduct manufactured between April 3, 2012 and May 14, 2013 and can be identified by their expiration date; between April 2017 and May 2018.

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2314-2013
FDA event ID
65697
Recalling firm
Atrium Medical, Hudson, NH
Classification
Class II
Status
Terminated
Recall initiated
12 Jul 2013
FDA classified
30 Sep 2013
Reported
9 Oct 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

12 Jul 2013Recall initiated by company
30 Sep 2013Classified by FDA+80 days
9 Oct 2013Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Inner tray label may adhere to wall of outer tray which make it difficult to remove the tray onto the sterile field

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Flixene Trumpet Grafts >or= 6mm Flixene GW and GWT Grafts >or= 6mm Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.

Where it was distributed

Worldwide Distribution - USA (nationwide) and internationally to the following countries: American Samoa Antilles Argentina Australia Austria Bangladesh Belgium Bolivia Brazil Canada Chile Colombia Egypt El Salvador Finland France Germany Great Britain Greece Guatemala Hong Kong India Indonesia Ireland Italy Jamaica Japan Korea Lebanon Libya Malaysia Mauritius Mexico Neal New Zealand Nicaragua Norway Pakistan Panama Peru Philippines Poland Portugal Puerto Rico Romania Russia Saudi Arabia Singapore Slovenia South Africa Spain Switzerland Taiwan Thailand the Netherlands Trinidad Tunisia

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Inner tray label may adhere to wall of outer tray which make it difficult to remove the tray onto the sterile field

Which lots are affected?

Product manufactured between April 3, 2012 and May 14, 2013 and can be identified by their expiration date; between April 2017 and May 2018.

Where was it sold?

Worldwide Distribution - USA (nationwide) and internationally to the following countries: American Samoa Antilles Argentina Australia Austria Bangladesh Belgium Bolivia Brazil Canada Chile Colombia Egypt El Salvador Finland France Germany Great Britain Greece Guatemala Hong Kong India Indonesia Ireland Italy Jamaica Japan Korea Lebanon Libya Malaysia Mauritius Mexico Neal New Zealand Nicaragua Norway Pakistan Panama Peru Philippines Poland Portugal Puerto Rico Romania Russia Saudi Arabia Singapore Slovenia South Africa Spain Switzerland Taiwan Thailand the Netherlands Trinidad Tunisia

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

13 other products · FDA event 65697

This product is part of a recall event; the main page for the event is Flixene Grafts >or= Intended for use recalled by Atrium Medical.

ReportedClassRecallCompanyReasonWhere
CLASS IIFlixene Grafts >or= Intended for use recalled by Atrium MedicalAtrium MedicalSterilityNationwide
CLASS IIAdvanta VS Grafts >or= Intended for use recalled by Atrium MedicalAtrium MedicalSterilityNationwide
CLASS IIAdvanta VXT Vascular Grafts >or= Intended for use recalledAtrium MedicalSterilityNationwide
CLASS IIAdvanta VXT Grafts < Intended for use recalled by Atrium MedicalAtrium MedicalSterilityNationwide
CLASS IIAdvanta SST Bifurcated Grafts >or= Intended for use recalledAtrium MedicalSterilityNationwide
CLASS IIAdvanta SST Grafts < Intended for use recalled by Atrium MedicalAtrium MedicalSterilityNationwide
CLASS IIAdvanta SuperSoft Grafts < Intended for use recalled by Atrium MedicalAtrium MedicalSterilityNationwide
CLASS IIFlixene IFG with Assisted Delivery Intended for use recalledAtrium MedicalSterilityNationwide
CLASS IIAdvanta SuperSoft Grafts >or= Intended for use recalledAtrium MedicalSterilityNationwide
CLASS IIAdvanta VS Grafts < Intended for use recalled by Atrium MedicalAtrium MedicalSterilityNationwide
CLASS IIAdvanta SST Grafts < Intended for use recalled by Atrium MedicalAtrium MedicalSterilityNationwide
CLASS IIAdvanta SST Grafts >or= Intended for use recalled by Atrium MedicalAtrium MedicalSterilityNationwide
CLASS IIFlixene IFG Vascular Grafts >or= Intended for use recalledAtrium MedicalSterilityNationwide

More recalls from Atrium Medical

All 153

Other Heart & Vascular Devices recalls

All 6,199